Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2010 1
2017 1
2018 1
2020 2
2021 1
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean mathew mathew (117 results)?
Single-cell RNA sequencing reveals distinct T cell populations in immune-related adverse events of checkpoint inhibitors.
Bukhari S, Henick BS, Winchester RJ, Lerrer S, Adam K, Gartshteyn Y, Maniar R, Lin Z, Khodadadi-Jamayran A, Tsirigos A, Salvatore MM, Lagos GG, Reiner SL, Dallos MC, Mathew M, Rizvi NA, Mor A. Bukhari S, et al. Among authors: mathew m. Cell Rep Med. 2023 Jan 17;4(1):100868. doi: 10.1016/j.xcrm.2022.100868. Epub 2022 Dec 12. Cell Rep Med. 2023. PMID: 36513074 Free PMC article.
Combining chemotherapy with PD-1 blockade in NSCLC.
Mathew M, Enzler T, Shu CA, Rizvi NA. Mathew M, et al. Pharmacol Ther. 2018 Jun;186:130-137. doi: 10.1016/j.pharmthera.2018.01.003. Epub 2018 Jan 31. Pharmacol Ther. 2018. PMID: 29352857 Review.
Extracellular Vesicles as Biomarkers in Cancer Immunotherapy.
Mathew M, Zade M, Mezghani N, Patel R, Wang Y, Momen-Heravi F. Mathew M, et al. Cancers (Basel). 2020 Sep 30;12(10):2825. doi: 10.3390/cancers12102825. Cancers (Basel). 2020. PMID: 33007968 Free PMC article. Review.
Characteristics and outcomes of lung cancer in solid organ transplant recipients.
Chen LN, Spivack J, Cao T, Saqi A, Benvenuto LJ, Bulman WA, Mathew M, Stoopler MB, Arcasoy SM, Stanifer BP, Rizvi NA, Shu CA. Chen LN, et al. Among authors: mathew m. Lung Cancer. 2020 Aug;146:297-302. doi: 10.1016/j.lungcan.2020.06.018. Epub 2020 Jun 20. Lung Cancer. 2020. PMID: 32619780
INDUCE-2: A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumors.
Hilton JF, Ott PA, Hansen AR, Li Z, Mathew M, Messina CH, Dave V, Ji X, Karpinich NO, Hirschfeld S, Ballas M, Zandberg DP. Hilton JF, et al. Among authors: mathew m. Cancer Immunol Immunother. 2024 Feb 13;73(3):44. doi: 10.1007/s00262-023-03623-z. Cancer Immunol Immunother. 2024. PMID: 38349570 Free PMC article. Clinical Trial.
Modulation of angiotensin II-mediated cardiac remodeling by the MEF2A target gene Xirp2.
McCalmon SA, Desjardins DM, Ahmad S, Davidoff KS, Snyder CM, Sato K, Ohashi K, Kielbasa OM, Mathew M, Ewen EP, Walsh K, Gavras H, Naya FJ. McCalmon SA, et al. Among authors: mathew m. Circ Res. 2010 Mar 19;106(5):952-60. doi: 10.1161/CIRCRESAHA.109.209007. Epub 2010 Jan 21. Circ Res. 2010. PMID: 20093629 Free PMC article.